Cytoskeleton and Cancer Progression

Websitehttps://www.lih.lu/en/research-scope/research-department/department-of-cancer-research/cytoskeleton-and-cancer-progression/

2 Not started
7 Active
8 Finished

17 results

Active
ACTIDRUG: High-content drug screening to inhibit actin cytoskeleton-mediated cancer immune evasion
Thomas, C. & Mgrditchian, T.
1/10/22 → 30/09/24
Project: Research
Synapodia: Novel synaptic filopodium-like protrusions (SFPs) protect tumor cells against cytotoxic lymphocyte-mediated killing
Thomas, C., Filali, L. & Moreau, F.
FNR - Fonds National de la Recherche, Fondation Cancer
15/07/22 → 14/10/24
Project: Research
I2TRON Elena Ockfen: Biological and clinical implications of PD-L1 protein polarization at the tumor tissue and cell levels
Thomas, C. & Ockfen, E.
FNR - Fonds National de la Recherche
1/03/21 → 28/02/25
Project: Research
TRANSACTINg: Unraveling the genetic pathways underlying actin remodeling-mediated cancer immune evasion
Thomas, C., Skupin, A. & Krecke, M.
FNRS - Fonds National de la Recherche Scientifique
1/01/21 → 31/12/24
Project: Research
ACTIVASION: Actin cytoskeleton remodeling in tumor immune evasion - mechanisticaspects
Thomas, C.
FNR - Fonds National de la Recherche
15/07/20 → 14/02/24
Project: Research
ACTIPHAGY: Actin remodeling in autophagy-mediated tumor immune escape,mechanistic aspects
Thomas, C., Janji, B. & Biolato, A. M.
FNRS - Fonds National de la Recherche Scientifique
1/12/19 → 30/04/24
Project: Research
ACTIMMUNE 2: OVERCOMING TUMOR IMMUNE EVASION BY TARGETING THE ACTIN RESPONSE
Thomas, C.
Fondation Cancer
1/06/19 → 31/05/24
Project: Research
Not started

ACTICAM: Role of ICAM-1 in mediating actin remodeling-dependent tumor immune evasion
Thomas, C. & Pereira Fernandes, D.
1/10/23 → 30/09/25
Project: Research
CANBIO2 (NN - Project 3): Reciprocal effects of intrinsic tumour immune resistance and the tumour microenvironment
Thomas, C.
FNR - Fonds National de la Recherche
Project: Research
Finished
INTERACTINg: Targeting a key promoter of multiple pro-metastatic pathways in breast cancer
Thomas, C., Dittmar, G. & Berro, F.
FNRS - Fonds National de la Recherche Scientifique
1/03/21 → 28/02/23
Project: Research
CRP2-TME: CRP2, an innovative target for metastatic breast cancer, with multiple rolesin the tumour and tumour microenvironmen
Thomas, C. & Berchem, G.
FNRS - Fonds National de la Recherche Scientifique
1/01/20 → 31/12/21
Project: Research
Think Pink II: The Student Training Project
Thomas, C.
Think Pink Luxembourg
1/01/18 → 31/12/19
Project: Other
METASTALIM: Inhibition of breast cancer metastasis by targeting critical cytoskeletal components of invadopodia
Thomas, C. & Mao, X.
FNR - Fonds National de la Recherche
1/09/17 → 30/11/19
Project: Research
CANBIO (Hannah Wurzer): Tumour microenvironment-induced invadopodia formation in cancer-associated fibroblasts: role in tumour cell invasion and metastasis
Thomas, C. & Wurzer, H.
FNR - Fonds National de la Recherche
1/02/17 → 31/01/21
Project: Research
METABLOCK: CRP2, an innovative target to inhibit invadopodia activity and pro-metastatic MMP expression in breast cancer
Thomas, C.
FNRS - Fonds National de la Recherche Scientifique
1/01/17 → 31/12/18
Project: Research
INVADOLIM: A LIM domain protein with multiple roles in breast cancer progression and metastas
Thomas, C. & Mao, X.
Fondation Cancer
1/05/16 → 30/04/18
Project: Research
INVADOBLOCK: Inhibition of Breast Cancer Metastasis by Co-targeting Two Actin Regulators
Thomas, C.
Think Pink Luxembourg
1/01/16 → 31/12/17
Project: Research